Abstract | AIMS: To test whether the dose-dependent motivation-suppressing effect of baclofen in animals could be transposed to humans, and suppress craving and sustain abstinence. METHODS: Neurologists safely use up to 300 mg/day (10 times the dosage currently used for alcohol dependence) of high-dose oral baclofen, to control spasticity, in order to avoid invasive therapy. I am a physician with alcohol dependence and comorbid anxiety. I self-prescribed high-dose baclofen, starting at 30 mg/day, with 20 mg increments every third day and an (optional) additional 20-40 mg/day for cravings. RESULTS: Cravings became easier to combat. After reaching the craving-suppression dose of 270 mg/day (3.6 mg/kg) after 5 weeks, I became and have remained free of alcohol dependence symptoms effortlessly for the ninth consecutive month. Anxiety is well controlled. Somnolence disappeared with a dosage reduction to 120 mg/day, now used for the eighth consecutive month. CONCLUSIONS: High-dose baclofen induced complete and prolonged suppression of symptoms and consequences of alcohol dependence, and relieved anxiety. This model, integrating cure and well-being, should be tested in randomized trials, under medical surveillance. It offers a new concept: medication-induced, dose-dependent, complete and prolonged suppression of substance-dependence symptoms with alleviation of comorbid anxiety.
|
Authors | Olivier Ameisen |
Journal | Alcohol and alcoholism (Oxford, Oxfordshire)
(Alcohol Alcohol)
2005 Mar-Apr
Vol. 40
Issue 2
Pg. 147-50
ISSN: 0735-0414 [Print] England |
PMID | 15596425
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
|
Topics |
- Alcoholism
(drug therapy, prevention & control, psychology)
- Anxiety Disorders
(drug therapy, prevention & control, psychology)
- Baclofen
(administration & dosage)
- Diagnosis, Dual (Psychiatry)
- Drug Administration Schedule
- Humans
- Male
- Middle Aged
- Physician Impairment
(psychology)
- Self Care
(methods)
- Self Disclosure
|